For the 5 tests, the cumulative probabilities of very abnormal laboratory results varied from 0.2% for leukocyte count to 6.6% for eGFR at 2 years and from 0.3 to 11%, respectively, at 5 years.

Thus far, the promise of precision medicine has been directed largely toward the field of oncology in terms of recommending personalized treatments based on molecular diagnostics tests. But ...

Please provide your email address to receive an email when new articles are posted on . Medicare will begin offering coverage for PrismRA, a molecular diagnostic test that predicts treatment response ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Augurex Life Sciences Corp., a leader in autoimmune biomarker-based diagnostics, today announced that ARUP Laboratories, a leading national reference ...

Seven years ago, Northeastern graduate Susan Dina Ghiassian was the first employee of Scipher Medicine Corp., a precision medicine company co-founded by Northeastern professor Albert-László Barabási.

Augurex expands its 14-3-3eta test availability through a new partnership with Sonic Reference Laboratory, a division of Sonic Healthcare USA, to enhance the diagnosis and management of rheumatoid ...

Rheumatoid arthritis (RA) is an autoimmune inflammatory disorder. It can affect the joints and other body systems. Doctors may find diagnosing RA challenging, as it may resemble various other ...

Share on Pinterest Scientists may have found a way to predict which biologics may work best for people with rheumatoid arthritis. Westend61/Getty Images Rheumatoid arthritis is a painful, progressive ...